CDKN2A and ovarian carcinoma: Similarly, a microarray analysis indicates that the cyclin‐dependent kinase 4 inhibitor A (p16INK4a) gene (CDKN2A) is upregulated in SALL2‐expressing versus SALL2‐null SKOV3 ovarian carcinoma cells (Wu et al., 2015).